Morphine is associated with acute chest syndrome in children hospitalized with sickle cell disease

Catherine S Birken1, Amina Khambalia, Annie Dupuis

  • 1Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada. catherine.birken@sickkids.ca

Hospital Pediatrics
|December 18, 2013
PubMed

Insights

Children with sickle cell disease (SCD) receiving morphine for pain may have an increased risk of acute chest syndrome (ACS). Close monitoring for ACS is recommended during hospitalization for SCD patients on morphine.

Area of Science:

  • Pediatric Hematology
  • Pain Management
  • Sickle Cell Disease Research

Background:

  • Sickle cell disease (SCD) is a genetic blood disorder.
  • Acute chest syndrome (ACS) is a common and serious complication of SCD.
  • Pain management is crucial for hospitalized SCD patients.

Purpose of the Study:

  • To investigate the association between intravenous morphine use and the development of acute chest syndrome (ACS).
  • To assess the risk of ACS in children with homozygous hemoglobin S SCD receiving morphine for acute pain.

Main Methods:

  • Retrospective review of health records for SCD patients aged 2-18 years hospitalized with acute pain.
  • Comparison of morphine dosage in patients who developed ACS (cases) versus those who did not (controls).
  • Survival analysis to determine the association between morphine dose and ACS incidence.

Main Results:

  • Morphine dosage in the hours preceding ACS was significantly associated with its development.
  • Patients who developed ACS received a higher mean morphine dose (40 microg/kg) compared to controls (34 microg/kg) one hour before ACS.
  • Each additional 10 microg/kg of morphine increased the risk of ACS by 23%.

Conclusions:

  • Intravenous morphine administration is associated with an increased risk of ACS in children with SCD.
  • Close observation for ACS symptoms is recommended for hospitalized SCD patients receiving morphine.
  • Further research may explore optimal pain management strategies to mitigate ACS risk.
Abstract

Related Concept Videos

Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.7K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.5K
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.3K
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
1.2K
Toxidromes: Clinical Features01:30

Toxidromes: Clinical Features

Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...
175
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.8K